| 0.5 |
1.5 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.3 |
1.2 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.3 |
0.8 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.7 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
0.8 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.2 |
0.7 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.2 |
0.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.9 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.2 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.5 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.2 |
1.4 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.2 |
0.5 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 |
0.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.6 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.4 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.4 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.1 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 |
0.4 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.4 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.1 |
0.4 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.1 |
1.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.9 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 |
0.2 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.1 |
0.3 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.5 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
1.4 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.3 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.3 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.1 |
0.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.3 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.3 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
1.0 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.3 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.1 |
0.3 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.1 |
0.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) positive regulation of male germ cell proliferation(GO:2000256) |
| 0.1 |
0.3 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.1 |
0.1 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
0.2 |
GO:1900453 |
negative regulation of long term synaptic depression(GO:1900453) |
| 0.1 |
0.1 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.1 |
0.2 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.2 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.1 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
0.4 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.3 |
GO:1903897 |
regulation of PERK-mediated unfolded protein response(GO:1903897) |
| 0.1 |
0.4 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.3 |
GO:0098904 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) regulation of AV node cell action potential(GO:0098904) |
| 0.1 |
0.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.5 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.1 |
0.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.4 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.5 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.2 |
GO:0010751 |
regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.1 |
0.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.2 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.1 |
1.2 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.2 |
GO:1904058 |
regulation of muscle atrophy(GO:0014735) regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of sensory perception of pain(GO:1904058) cholangiocyte proliferation(GO:1990705) |
| 0.1 |
0.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.2 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.3 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.3 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 |
0.2 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.3 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
0.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.7 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
0.2 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.4 |
GO:0032308 |
positive regulation of prostaglandin secretion(GO:0032308) |
| 0.1 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.3 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.1 |
0.3 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.3 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
0.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.5 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
2.6 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.0 |
0.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.2 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.8 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.6 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.8 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.0 |
0.7 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.7 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.2 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.0 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
0.2 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.1 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 |
0.2 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.3 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.2 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 |
0.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.1 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.2 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.6 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.3 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.0 |
0.4 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.1 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.0 |
0.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.5 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.1 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.0 |
0.5 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.2 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.0 |
1.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
0.1 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.0 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.0 |
0.1 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.4 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.3 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.2 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.0 |
0.2 |
GO:0022605 |
oogenesis stage(GO:0022605) |
| 0.0 |
0.4 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.1 |
GO:0006203 |
dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
| 0.0 |
0.3 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.0 |
0.3 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.3 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 |
0.2 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.0 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.0 |
0.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:2000110 |
protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 |
0.5 |
GO:0030431 |
sleep(GO:0030431) |
| 0.0 |
0.1 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 |
0.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.4 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.1 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.0 |
0.1 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.0 |
1.0 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
0.4 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.0 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 |
0.3 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.1 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.1 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.0 |
0.1 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.0 |
0.3 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
0.1 |
GO:1903215 |
regulation of mRNA modification(GO:0090365) negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.0 |
0.2 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.0 |
0.1 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.0 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 |
0.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.1 |
GO:0015692 |
nickel cation transport(GO:0015675) vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.0 |
0.3 |
GO:0099625 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.0 |
0.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.0 |
0.3 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.1 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.6 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.2 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.0 |
GO:1902861 |
copper ion import into cell(GO:1902861) |
| 0.0 |
0.1 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.5 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 |
0.0 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.0 |
0.1 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.0 |
0.5 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.0 |
0.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.1 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.1 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.0 |
GO:0071609 |
neutrophil mediated killing of bacterium(GO:0070944) chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.0 |
0.3 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.0 |
0.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.1 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.0 |
0.3 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.2 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.2 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.0 |
0.2 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.1 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.0 |
0.0 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
| 0.0 |
0.1 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.1 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.1 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
0.2 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.0 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.2 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.1 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.0 |
0.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.0 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.0 |
0.0 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.5 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.0 |
0.3 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.4 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.5 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.0 |
0.0 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.1 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
0.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.3 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.2 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.6 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.0 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.0 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.2 |
GO:1902855 |
regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.0 |
0.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.0 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.0 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.4 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.0 |
0.0 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 |
0.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.1 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.0 |
0.5 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.3 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.0 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.4 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.3 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.7 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.4 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.0 |
0.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.0 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 |
0.1 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
